Bloodstream yeast infections: a 15-month survey
A 15-month survey of 412 bloodstream yeast isolates from 54 Belgian hospitals was undertaken. Candida albicans was the most common species (47·3%) followed by C. glabrata (25·7%), C. parapsilosis (8·0%), C. tropicalis (6·8%) and Saccharomyces cerevisiae (5·1%). Common predisposing factors were antib...
Gespeichert in:
| Veröffentlicht in: | Epidemiology and infection 2009-07, Vol.137 (7), p.1037-1040 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1040 |
|---|---|
| container_issue | 7 |
| container_start_page | 1037 |
| container_title | Epidemiology and infection |
| container_volume | 137 |
| creator | SWINNE, D. NOLARD, N. VAN ROOIJ, P. DETANDT, M. |
| description | A 15-month survey of 412 bloodstream yeast isolates from 54 Belgian hospitals was undertaken. Candida albicans was the most common species (47·3%) followed by C. glabrata (25·7%), C. parapsilosis (8·0%), C. tropicalis (6·8%) and Saccharomyces cerevisiae (5·1%). Common predisposing factors were antibacterial therapy (45%), hospitalization in intensive care units (34%), presence of in-dwelling catheters (32%), underlying cancer (23%) and major surgery (11%). Most patients had more than one predisposing factor. Fluconazole alone or in combination with another antifungal agent was the treatment of choice for 86·6% of the cases. Susceptibility testing revealed that 93·5% were susceptible to amphotericin B, 39·6% to itraconazole, 42·8% to fluconazole and 87% to voriconazole. Resistance to azoles was more common among C. glabrata isolates. |
| doi_str_mv | 10.1017/S0950268808001763 |
| format | Article |
| fullrecord | <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_67283117</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cupid>10_1017_S0950268808001763</cupid><jstor_id>30221712</jstor_id><sourcerecordid>30221712</sourcerecordid><originalsourceid>FETCH-LOGICAL-c534t-f70d5d3ef61292a996d2d2882f0e8e824d14e2e5188c3edb71c7d6b0efb19d473</originalsourceid><addsrcrecordid>eNqFkF2L1TAQhoMo7nH1B3ihFEHv6mbynb3TRXeVZUVUBG9K2ky1x7ZZk1Y8_96UU86CIl6F4XlmwvsS8hDoc6CgTz5QKylTxlBD86z4LbIBoWwpBLW3yWbB5cKPyL2UtpRSy4y-S47AAheM8w05edmH4NMU0Q3FDl2aim5ssZm6MKbTwhUgyyGM07cizfEn7u6TO63rEz5Y32Py6fWrj2cX5eW78zdnLy7LRnIxla2mXnqOrQJmmbNWeeaZMaylaNAw4UEgQwnGNBx9raHRXtUU2xqsF5ofk2f7u9cx_JgxTdXQpQb73o0Y5lQpzQwH-L_IKGPKKpnFJ3-I2zDHMYfIjhRWC1gk2EtNDClFbKvr2A0u7iqg1dJ59VfneefxeniuB_Q3G2vJWXi6Ci41rm-jG5suHTwG0uRmls8f7b1tmkI8cJ4TgAaWebnnXZrw14G7-D3XwbWs1Pn7Ci6u3tIvn6G6yj5fw7ihjp3_ijeR_x3nN3QCrhE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>205497415</pqid></control><display><type>article</type><title>Bloodstream yeast infections: a 15-month survey</title><source>MEDLINE</source><source>JSTOR Archive Collection A-Z Listing</source><source>PubMed Central</source><creator>SWINNE, D. ; NOLARD, N. ; VAN ROOIJ, P. ; DETANDT, M.</creator><creatorcontrib>SWINNE, D. ; NOLARD, N. ; VAN ROOIJ, P. ; DETANDT, M.</creatorcontrib><description>A 15-month survey of 412 bloodstream yeast isolates from 54 Belgian hospitals was undertaken. Candida albicans was the most common species (47·3%) followed by C. glabrata (25·7%), C. parapsilosis (8·0%), C. tropicalis (6·8%) and Saccharomyces cerevisiae (5·1%). Common predisposing factors were antibacterial therapy (45%), hospitalization in intensive care units (34%), presence of in-dwelling catheters (32%), underlying cancer (23%) and major surgery (11%). Most patients had more than one predisposing factor. Fluconazole alone or in combination with another antifungal agent was the treatment of choice for 86·6% of the cases. Susceptibility testing revealed that 93·5% were susceptible to amphotericin B, 39·6% to itraconazole, 42·8% to fluconazole and 87% to voriconazole. Resistance to azoles was more common among C. glabrata isolates.</description><identifier>ISSN: 0950-2688</identifier><identifier>EISSN: 1469-4409</identifier><identifier>DOI: 10.1017/S0950268808001763</identifier><identifier>PMID: 19134233</identifier><identifier>CODEN: EPINEU</identifier><language>eng</language><publisher>Cambridge, UK: Cambridge University Press</publisher><subject>Antifungal Agents - therapeutic use ; Antifungal susceptibilities ; Antifungals ; Antimicrobials ; Bacterial diseases ; Bacterial sepsis ; Belgium - epidemiology ; Biological and medical sciences ; bloodstream infections ; Candida ; candidiasis ; Fundamental and applied biological sciences. Psychology ; Fungal infections ; Fungemia - drug therapy ; Fungemia - epidemiology ; Health surveys ; Human bacterial diseases ; Humans ; Infections ; Infectious diseases ; Medical sciences ; Microbiology ; Predisposing factors ; Public health ; Risk Factors ; Saccharomyces cerevisiae ; Septicaemia, pneumococci ; Short Report ; Yeast ; Yeasts</subject><ispartof>Epidemiology and infection, 2009-07, Vol.137 (7), p.1037-1040</ispartof><rights>Copyright © 2009 Cambridge University Press</rights><rights>Copyright 2009 Cambridge University Press</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c534t-f70d5d3ef61292a996d2d2882f0e8e824d14e2e5188c3edb71c7d6b0efb19d473</citedby><cites>FETCH-LOGICAL-c534t-f70d5d3ef61292a996d2d2882f0e8e824d14e2e5188c3edb71c7d6b0efb19d473</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/30221712$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/30221712$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,780,784,803,27924,27925,58017,58250</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21588825$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19134233$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>SWINNE, D.</creatorcontrib><creatorcontrib>NOLARD, N.</creatorcontrib><creatorcontrib>VAN ROOIJ, P.</creatorcontrib><creatorcontrib>DETANDT, M.</creatorcontrib><title>Bloodstream yeast infections: a 15-month survey</title><title>Epidemiology and infection</title><addtitle>Epidemiol. Infect</addtitle><description>A 15-month survey of 412 bloodstream yeast isolates from 54 Belgian hospitals was undertaken. Candida albicans was the most common species (47·3%) followed by C. glabrata (25·7%), C. parapsilosis (8·0%), C. tropicalis (6·8%) and Saccharomyces cerevisiae (5·1%). Common predisposing factors were antibacterial therapy (45%), hospitalization in intensive care units (34%), presence of in-dwelling catheters (32%), underlying cancer (23%) and major surgery (11%). Most patients had more than one predisposing factor. Fluconazole alone or in combination with another antifungal agent was the treatment of choice for 86·6% of the cases. Susceptibility testing revealed that 93·5% were susceptible to amphotericin B, 39·6% to itraconazole, 42·8% to fluconazole and 87% to voriconazole. Resistance to azoles was more common among C. glabrata isolates.</description><subject>Antifungal Agents - therapeutic use</subject><subject>Antifungal susceptibilities</subject><subject>Antifungals</subject><subject>Antimicrobials</subject><subject>Bacterial diseases</subject><subject>Bacterial sepsis</subject><subject>Belgium - epidemiology</subject><subject>Biological and medical sciences</subject><subject>bloodstream infections</subject><subject>Candida</subject><subject>candidiasis</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Fungal infections</subject><subject>Fungemia - drug therapy</subject><subject>Fungemia - epidemiology</subject><subject>Health surveys</subject><subject>Human bacterial diseases</subject><subject>Humans</subject><subject>Infections</subject><subject>Infectious diseases</subject><subject>Medical sciences</subject><subject>Microbiology</subject><subject>Predisposing factors</subject><subject>Public health</subject><subject>Risk Factors</subject><subject>Saccharomyces cerevisiae</subject><subject>Septicaemia, pneumococci</subject><subject>Short Report</subject><subject>Yeast</subject><subject>Yeasts</subject><issn>0950-2688</issn><issn>1469-4409</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqFkF2L1TAQhoMo7nH1B3ihFEHv6mbynb3TRXeVZUVUBG9K2ky1x7ZZk1Y8_96UU86CIl6F4XlmwvsS8hDoc6CgTz5QKylTxlBD86z4LbIBoWwpBLW3yWbB5cKPyL2UtpRSy4y-S47AAheM8w05edmH4NMU0Q3FDl2aim5ssZm6MKbTwhUgyyGM07cizfEn7u6TO63rEz5Y32Py6fWrj2cX5eW78zdnLy7LRnIxla2mXnqOrQJmmbNWeeaZMaylaNAw4UEgQwnGNBx9raHRXtUU2xqsF5ofk2f7u9cx_JgxTdXQpQb73o0Y5lQpzQwH-L_IKGPKKpnFJ3-I2zDHMYfIjhRWC1gk2EtNDClFbKvr2A0u7iqg1dJ59VfneefxeniuB_Q3G2vJWXi6Ci41rm-jG5suHTwG0uRmls8f7b1tmkI8cJ4TgAaWebnnXZrw14G7-D3XwbWs1Pn7Ci6u3tIvn6G6yj5fw7ihjp3_ijeR_x3nN3QCrhE</recordid><startdate>20090701</startdate><enddate>20090701</enddate><creator>SWINNE, D.</creator><creator>NOLARD, N.</creator><creator>VAN ROOIJ, P.</creator><creator>DETANDT, M.</creator><general>Cambridge University Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T2</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20090701</creationdate><title>Bloodstream yeast infections: a 15-month survey</title><author>SWINNE, D. ; NOLARD, N. ; VAN ROOIJ, P. ; DETANDT, M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c534t-f70d5d3ef61292a996d2d2882f0e8e824d14e2e5188c3edb71c7d6b0efb19d473</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Antifungal Agents - therapeutic use</topic><topic>Antifungal susceptibilities</topic><topic>Antifungals</topic><topic>Antimicrobials</topic><topic>Bacterial diseases</topic><topic>Bacterial sepsis</topic><topic>Belgium - epidemiology</topic><topic>Biological and medical sciences</topic><topic>bloodstream infections</topic><topic>Candida</topic><topic>candidiasis</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Fungal infections</topic><topic>Fungemia - drug therapy</topic><topic>Fungemia - epidemiology</topic><topic>Health surveys</topic><topic>Human bacterial diseases</topic><topic>Humans</topic><topic>Infections</topic><topic>Infectious diseases</topic><topic>Medical sciences</topic><topic>Microbiology</topic><topic>Predisposing factors</topic><topic>Public health</topic><topic>Risk Factors</topic><topic>Saccharomyces cerevisiae</topic><topic>Septicaemia, pneumococci</topic><topic>Short Report</topic><topic>Yeast</topic><topic>Yeasts</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>SWINNE, D.</creatorcontrib><creatorcontrib>NOLARD, N.</creatorcontrib><creatorcontrib>VAN ROOIJ, P.</creatorcontrib><creatorcontrib>DETANDT, M.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing & Allied Health Database</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Epidemiology and infection</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>SWINNE, D.</au><au>NOLARD, N.</au><au>VAN ROOIJ, P.</au><au>DETANDT, M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Bloodstream yeast infections: a 15-month survey</atitle><jtitle>Epidemiology and infection</jtitle><addtitle>Epidemiol. Infect</addtitle><date>2009-07-01</date><risdate>2009</risdate><volume>137</volume><issue>7</issue><spage>1037</spage><epage>1040</epage><pages>1037-1040</pages><issn>0950-2688</issn><eissn>1469-4409</eissn><coden>EPINEU</coden><abstract>A 15-month survey of 412 bloodstream yeast isolates from 54 Belgian hospitals was undertaken. Candida albicans was the most common species (47·3%) followed by C. glabrata (25·7%), C. parapsilosis (8·0%), C. tropicalis (6·8%) and Saccharomyces cerevisiae (5·1%). Common predisposing factors were antibacterial therapy (45%), hospitalization in intensive care units (34%), presence of in-dwelling catheters (32%), underlying cancer (23%) and major surgery (11%). Most patients had more than one predisposing factor. Fluconazole alone or in combination with another antifungal agent was the treatment of choice for 86·6% of the cases. Susceptibility testing revealed that 93·5% were susceptible to amphotericin B, 39·6% to itraconazole, 42·8% to fluconazole and 87% to voriconazole. Resistance to azoles was more common among C. glabrata isolates.</abstract><cop>Cambridge, UK</cop><pub>Cambridge University Press</pub><pmid>19134233</pmid><doi>10.1017/S0950268808001763</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0950-2688 |
| ispartof | Epidemiology and infection, 2009-07, Vol.137 (7), p.1037-1040 |
| issn | 0950-2688 1469-4409 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_67283117 |
| source | MEDLINE; JSTOR Archive Collection A-Z Listing; PubMed Central |
| subjects | Antifungal Agents - therapeutic use Antifungal susceptibilities Antifungals Antimicrobials Bacterial diseases Bacterial sepsis Belgium - epidemiology Biological and medical sciences bloodstream infections Candida candidiasis Fundamental and applied biological sciences. Psychology Fungal infections Fungemia - drug therapy Fungemia - epidemiology Health surveys Human bacterial diseases Humans Infections Infectious diseases Medical sciences Microbiology Predisposing factors Public health Risk Factors Saccharomyces cerevisiae Septicaemia, pneumococci Short Report Yeast Yeasts |
| title | Bloodstream yeast infections: a 15-month survey |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T08%3A45%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Bloodstream%20yeast%20infections:%20a%2015-month%20survey&rft.jtitle=Epidemiology%20and%20infection&rft.au=SWINNE,%20D.&rft.date=2009-07-01&rft.volume=137&rft.issue=7&rft.spage=1037&rft.epage=1040&rft.pages=1037-1040&rft.issn=0950-2688&rft.eissn=1469-4409&rft.coden=EPINEU&rft_id=info:doi/10.1017/S0950268808001763&rft_dat=%3Cjstor_proqu%3E30221712%3C/jstor_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=205497415&rft_id=info:pmid/19134233&rft_cupid=10_1017_S0950268808001763&rft_jstor_id=30221712&rfr_iscdi=true |